ADMA Biologics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade ADMA Biologics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ADMA

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. 

CEO
Adam S. Grossman
CEOAdam S. Grossman
Employees
685
Employees685
Headquarters
Ramsey, New Jersey
HeadquartersRamsey, New Jersey
Founded
2004
Founded2004
Employees
685
Employees685

ADMA Key Statistics

Market cap
3.98B
Market cap3.98B
Price-Earnings ratio
19.65
Price-Earnings ratio19.65
Dividend yield
Dividend yield
Average volume
2.60M
Average volume2.60M
High today
$17.74
High today$17.74
Low today
$16.63
Low today$16.63
Open price
$17.31
Open price$17.31
Volume
2.41M
Volume2.41M
52 Week high
$25.67
52 Week high$25.67
52 Week low
$13.50
52 Week low$13.50

Stock Snapshot

With a market cap of 3.98B, ADMA Biologics(ADMA) trades at $16.72. The stock has a price-to-earnings ratio of 19.65.

On 2026-01-24, ADMA Biologics(ADMA) stock moved within a range of $16.63 to $17.74. With shares now at $16.72, the stock is trading +0.5% above its intraday low and -5.7% below the session's peak.

Trading activity shows a volume of 2.41M, compared to an average daily volume of 2.6M.

Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $25.67 and a low of $13.50.

Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $25.67 and a low of $13.50.

ADMA News

Simply Wall St 2d
ADMA Biologics Is Down 5.0% After Expanding Multi-Year Revenue Guidance Targets - Has The Bull Case Changed?

In January 2026, ADMA Biologics raised its preliminary unaudited revenue guidance for 2025 to about US$510 million–US$511 million and lifted its 2026 outlook to...

ADMA Biologics Is Down 5.0% After Expanding Multi-Year Revenue Guidance Targets - Has The Bull Case Changed?
Simply Wall St 3d
High Growth US Tech Stocks To Watch In January 2026

As the U.S. market grapples with heightened geopolitical tensions and the threat of new tariffs, major indices like the Nasdaq and S&P 500 have experienced sign...

High Growth US Tech Stocks To Watch In January 2026

People also own

Based on the portfolios of people who own ADMA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.